GFGabriela Furlin

Gabriela Furlin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriela Furlin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interrater reliability for the detection of cortical lesions on phase-sensitive inversion recovery magnetic resonance imaging in patients with multiple sclerosis

    by Marco Aurelio Gralha de Caneda, Marjana Reis Lima Rizzo, Gabriela Furlin, Abraão Kupske, Bruna Bressan Valentini, Rafaela Fiss Ortiz, Camila Batista de Oliveira Silva, Maria Cecilia Aragon de Vecino

    Objective: To assess the reliability of phase-sensitive inversion recovery (PSIR) magnetic resonance imaging (MRI) and its accuracy for determining the topography of demyelinating cortical lesions in patients with multiple sclerosis (MS). Materials and Methods: This was a cross-sectional study conducted at a tertiary referral center for MS and other demyelinating disorders. We assessed the agreement among three raters for the detection and topographic classification of cortical lesions on fluid-attenuated inversion recovery (FLAIR) and PSIR sequences in patients with MS. Results: We recruited 71 patients with MS. The PSIR sequences detected 50% more lesions than did the FLAIR sequences. For detecting cortical lesions, the level of interrater agreement was satisfactory, with a mean free-response kappa (κFR) coefficient of 0.60, whereas the mean κFR for the topographic reclassification of the lesions was 0.57. On PSIR sequences, the raters reclassified 366 lesions (20% of the lesions detected on FLAIR sequences), with excellent interrater agreement. There was a significant correlation between the total number of lesions detected on PSIR sequences and the Expanded Disability Status Scale score (ρ = 0.35; p < 0.001). Conclusion: It seems that PSIR sequences perform better than do FLAIR sequences, with clinically satisfactory interrater agreement, for the detection and topographic classification of cortical lesions. In our sample of patients with MS, the PSIR MRI findings were significantly associated with the disability status, which could influence decisions regarding the treatment of such patients.


      • Vol. 58
    Open Access

    Quantitative MRI assessment in metabolic dysfunctionassociated steatotic liver disease: correlation between the MRI-PDFF and liver size

    by Gabriela Carboni, Louise Torres, Gabriela Furlin, Gabriela Sequeira de Campos Morais, Rubia Vanceta, Caroline Lorenzoni Almeida Ghezzi, Henrique Meira Guerra, Alice Schuch

    To evaluate the relationship between the magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) and liver size in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), as well as to explore the role of determining the craniocaudal diameter of the right hepatic lobe (CCDHL), measured at the midclavicular line, and liver volumetry as complementary tools in the assessment of hepatic steatosis. This was a single-center, cross-sectional, prospective study including 289 patients with MASLD who underwent multiparametric MRI for the evaluation of hepatic steatosis, which was categorized by the MRI-PDFF value. Liver size measurements included the CCDHL, liver volume from automated segmentation, and its difference from the total expected liver volume (eLV), calculated with the Vauthey formula. A significant positive correlation was observed between the MRI-PDFF and liver size measurements, including the CCDHL (rs = 0.651; p < 0.001) and the eLV (rs = 0.568; p < 0.001). Patients with higher grades of steatosis showed a progressive increase in liver volume (p < 0.001). A receiver operating characteristic curve analysis demonstrated good diagnostic accuracy for the CCDHL and for the eLV in identifying moderate-to-severe steatosis (area under the curve: 0.76 and 0.83, respectively). The integrated assessment of the MRI-PDFF and liver size appears to be effective for the diagnosis, stratification, and monitoring of steatosis in patients with MASLD.